ArticleFrontiers in public health2025

Cost-effectiveness analysis of Chinese patent medicines for the treatment of postmenopausal osteoporosis in China.

Cong Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.